PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PBE vs. IDNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between PBE and IDNA is 0.86, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

PBE vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
32.10%
-5.20%
PBE
IDNA

Key characteristics

Sharpe Ratio

PBE:

0.31

IDNA:

0.20

Sortino Ratio

PBE:

0.56

IDNA:

0.43

Omega Ratio

PBE:

1.07

IDNA:

1.05

Calmar Ratio

PBE:

0.20

IDNA:

0.07

Martin Ratio

PBE:

1.34

IDNA:

0.76

Ulcer Index

PBE:

4.37%

IDNA:

5.66%

Daily Std Dev

PBE:

18.58%

IDNA:

21.03%

Max Drawdown

PBE:

-45.69%

IDNA:

-68.26%

Current Drawdown

PBE:

-19.74%

IDNA:

-57.94%

Returns By Period

In the year-to-date period, PBE achieves a 2.15% return, which is significantly higher than IDNA's -0.68% return.


PBE

YTD

2.15%

1M

-0.62%

6M

3.23%

1Y

3.91%

5Y*

3.57%

10Y*

3.42%

IDNA

YTD

-0.68%

1M

-1.61%

6M

-4.22%

1Y

2.48%

5Y*

-4.97%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PBE vs. IDNA - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than IDNA's 0.47% expense ratio.


PBE
Invesco Dynamic Biotechnology & Genome ETF
Expense ratio chart for PBE: current value at 0.59% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.59%
Expense ratio chart for IDNA: current value at 0.47% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.47%

Risk-Adjusted Performance

PBE vs. IDNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PBE, currently valued at 0.31, compared to the broader market0.002.004.000.310.20
The chart of Sortino ratio for PBE, currently valued at 0.56, compared to the broader market-2.000.002.004.006.008.0010.000.560.43
The chart of Omega ratio for PBE, currently valued at 1.07, compared to the broader market0.501.001.502.002.503.001.071.05
The chart of Calmar ratio for PBE, currently valued at 0.20, compared to the broader market0.005.0010.0015.000.200.07
The chart of Martin ratio for PBE, currently valued at 1.34, compared to the broader market0.0020.0040.0060.0080.00100.001.340.76
PBE
IDNA

The current PBE Sharpe Ratio is 0.31, which is higher than the IDNA Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of PBE and IDNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.31
0.20
PBE
IDNA

Dividends

PBE vs. IDNA - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 0.05%, less than IDNA's 0.98% yield.


TTM2023202220212020201920182017201620152014
PBE
Invesco Dynamic Biotechnology & Genome ETF
0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
0.98%1.04%0.54%0.70%0.26%0.80%0.00%0.00%0.00%0.00%0.00%

Drawdowns

PBE vs. IDNA - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for PBE and IDNA. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%JulyAugustSeptemberOctoberNovemberDecember
-19.74%
-57.94%
PBE
IDNA

Volatility

PBE vs. IDNA - Volatility Comparison

The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 5.85%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 6.42%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%JulyAugustSeptemberOctoberNovemberDecember
5.85%
6.42%
PBE
IDNA
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab